Analyze Diet
Journal of veterinary pharmacology and therapeutics2012; 36(4); 389-398; doi: 10.1111/jvp.12009

Pharmacokinetics and pharmacodynamics of tramadol in horses following oral administration.

Abstract: Tramadol is a synthetic opioid used in human medicine, and to a lesser extent in veterinary medicine, for the treatment of both acute and chronic pain. In humans, the analgesic effects are owing to the actions of both the parent compound and an active metabolite (M1). The goal of the current study was to extend current knowledge of the pharmacokinetics of tramadol and M1 following oral administration of three doses of tramadol to horses. A total of nine healthy adult horses received a single oral administration of 3, 6, and 9 mg/kg of tramadol via nasogastric tube. Blood samples were collected at time 0 and at various times up to 96 h after drug administration. Urine samples were collected until 120 h after administration. Plasma and urine samples were analyzed using liquid chromatography-mass spectrometry, and the resulting data analyzed using noncompartmental analysis. For the 3, 6, and 9 mg/kg dose groups, Cmax , Tmax, and the t1/2λ were 43.1, 90.7, and 218 ng/mL, 0.750, 2.0, and 1.5 h and 2.14, 2.25, and 2.39 h, respectively. While tramadol and M1 plasma concentrations within the analgesic range for humans were attained in the 3 and 6 mg/kg dose group, these concentrations were at the lower end of the analgesic range and were only transiently maintained. Furthermore, until effective analgesic plasma concentrations have been established in horses, tramadol should be cautiously recommended for control of pain in horses. No significant undesirable behavioral or physiologic effects were noted at any of the doses administered.
Publication Date: 2012-10-13 PubMed ID: 23061925DOI: 10.1111/jvp.12009Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research investigates the effects of differing doses of tramadol, a synthetic opioid, on horses. The study aims to deepen understanding of the drug’s pharmacokinetics, which is how a drug moves through the body, and its pharmacodynamics, or how it affects the body.

Research Methodology

The research involved nine healthy adult horses which received one of three doses (3, 6, and 9 mg/kg) of tramadol, orally via a nasogastric tube. The study focused on two substances: tramadol itself and its active metabolite known as M1.

  • Blood samples from the horses were collected at several time points, starting from time zero (when the drug was administered), and up to 96 hours post-administration.
  • Urine samples were also collected up to 120 hours after administration.
  • The samples’ plasma and urine were examined using liquid chromatography-mass spectrometry, a technique commonly used to analyze organic compounds.
  • The gathered data from these tests was processed using noncompartmental analysis, a mathematical approach aimed at deriving useful information from drug concentration time data.

Research Findings

Key parameters of pharmacokinetics were reported for the 3, 6, and 9 mg/kg dosage groups which included maximum concentration (Cmax), time to reach maximum concentration (Tmax), and half-life (t1/2λ).

  • For the mentioned dosages, the Cmax values were 43.1, 90.7, and 218 ng/mL, respectively. Tmax was noted to be 0.750, 2.0, and 1.5 hours, and t1/2λ was around 2.14, 2.25, and 2.39 hours.
  • The study revealed that tramadol and its active metabolite M1 were present in plasma concentrations within the analgesic range for humans in the 3 and 6 mg/kg dose groups. However, the concentrations were at the lower end of this range and were maintained only for a short time.

Conclusion and Recommendations

The research makes it clear there’s a need for establishing effective analgesic plasma concentration in horses as the levels reached in this study were at the lower end and short-lived. Therefore, the study advises that prescriptions of tramadol for pain control in horses should be made cautiously. Despite variations in dose levels, no significant negative behavioral or physiological effects were observed in any of the horses.

Cite This Article

APA
Knych HK, Corado CR, McKemie DS, Scholtz E, Sams R. (2012). Pharmacokinetics and pharmacodynamics of tramadol in horses following oral administration. J Vet Pharmacol Ther, 36(4), 389-398. https://doi.org/10.1111/jvp.12009

Publication

ISSN: 1365-2885
NlmUniqueID: 7910920
Country: England
Language: English
Volume: 36
Issue: 4
Pages: 389-398

Researcher Affiliations

Knych, H K
  • K.L. Maddy Equine Analytical Chemistry Laboratory, School of Veterinary Medicine, University of California, Davis, CA 95616, USA. hkknych@ucdavis.edu
Corado, C R
    McKemie, D S
      Scholtz, E
        Sams, R

          MeSH Terms

          • Administration, Oral
          • Analgesics, Opioid / blood
          • Analgesics, Opioid / pharmacokinetics
          • Analgesics, Opioid / pharmacology
          • Animals
          • Area Under Curve
          • Dose-Response Relationship, Drug
          • Half-Life
          • Horses / blood
          • Tramadol / blood
          • Tramadol / pharmacokinetics
          • Tramadol / pharmacology

          Citations

          This article has been cited 2 times.
          1. Carregaro AB, Freitas GC, Ribeiro MH, Xavier NV, Dória RG. Physiological and analgesic effects of continuous-rate infusion of morphine, butorphanol, tramadol or methadone in horses with lipopolysaccharide (LPS)-induced carpal synovitis.. BMC Vet Res 2014 Dec 21;10:966.
            doi: 10.1186/s12917-014-0299-zpubmed: 25528353google scholar: lookup
          2. Kelly KR, Pypendop BH, Christe KL. Pharmacokinetics of tramadol following intravenous and oral administration in male rhesus macaques (Macaca mulatta).. J Vet Pharmacol Ther 2015 Aug;38(4):375-82.
            doi: 10.1111/jvp.12194pubmed: 25488714google scholar: lookup